Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price was up 14.1% during trading on Tuesday . The stock traded as high as GBX 2.19 ($0.03) and last traded at GBX 2.17 ($0.03). Approximately 1,074,848 shares changed hands during trading, a decline of 33% from the average daily volume of 1,601,397 shares. The stock had previously closed at GBX 1.90 ($0.02).
Cizzle Biotechnology Trading Up 14.1 %
The stock’s fifty day moving average price is GBX 1.79 and its 200 day moving average price is GBX 1.86. The stock has a market cap of £8.59 million, a P/E ratio of -216.70 and a beta of 0.38.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- Health Care Stocks Explained: Why You Might Want to Invest
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- What Does a Stock Split Mean?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Retail Stocks Investing, Explained
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
